Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease

Title
Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease
Authors
Keywords
Mouse models, Cognitive impairment, Alzheimer's disease, Hippocampus, Heme, Mice, Synapses, Astrocytes
Journal
PLoS One
Volume 14, Issue 4, Pages e0215004
Publisher
Public Library of Science (PLoS)
Online
2019-04-12
DOI
10.1371/journal.pone.0215004

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started